Fredun Pharmaceuticals Ltd — Important, 18-12-2025: Company Update

Fredun Pharmaceuticals has issued a corrigendum updating details of its preferential issue, revising the total issue size to ₹149.49 crore from an earlier ₹153.25 crore. The funds will fuel a strategic expansion into an Integrated Health, Wellness, and Pharmaceutical Division. This includes new Pet Care, Human Care (nutritional, cosmeceutical, dermatological solutions), and Pharma Generics divisions, aiming for diversified growth in domestic and international markets. The update also provides revised lists of allottees and their shareholdings.